Interethnic Comparisons of Important Pharmacology Genes Using SNP Databases: Potential Application to Drug Regulatory Assessments

• Teo YY , SimX, OngRTH et al.: Singapore Genome Variation Project: A haploytpe map of three South-East Asian populations.Genome Res.19(11) , 2154–2162 (2009).
   PubMed Web of Science ®Google Scholar
• Hapmap Consortium: A haplotype map of the human genome. Nature437(7063) , 1299–1320 (2005).
   PubMed Web of Science ®Google Scholar
• Sangkuhl K , BerlinDS, AltmanRB, KleinTE: PharmGKB: understanding the effects of individual genetic variants.Drug Metab. Rev.40(4) , 539–551 (2008).
   PubMed Web of Science ®Google Scholar
• Wright S : The genetical structure of populations.Ann. Eugen.15 , 323–354 (1951).
   PubMedGoogle Scholar
• Holsinger KE , WeirBS: Genetics in geographically structured populations: defining, estimating and interpreting Fst.Nat. Rev. Genet.10(9) , 639–650 (2009).
   PubMed Web of Science ®Google Scholar
• Meyer UA , ZangerUM: Molecular mechanisms of genetic polymorphisms of drug metabolism.Annu. Rev. Pharmacol. Toxicol.37 , 269–296 (1997).
   PubMed Web of Science ®Google Scholar
• Link E , ParishS, ArmitageJ et al.: SLCO1B1 variants and statin-induced myopathy – a genomewide study.N. Engl. J. Med.359(8) , 789–799 (2008).
   PubMed Web of Science ®Google Scholar
• de Bakker PI , YelenskyR, Pe‘erI, GabrielSB, DalyMJ, AltshulerD: Efficiency and power in genetic association studies.Nat. Genet.37(11) , 1217–1223 (2005).
   PubMed Web of Science ®Google Scholar
• Teo YY , SmallKS: A novel method for haplotype clustering and visualization.Genet. Epidemiol.34(1) , 34–41 (2009).
   Web of Science ®Google Scholar
• Conrad DF , JakobssonM, CoopG et al.: A worldwide survey of haplotype variation and linkage disequilibrium in the human genome.Nat. Genet.38(11) , 1251–1260 (2006).
   PubMed Web of Science ®Google Scholar
• Jakobsson M , ScholzSW, ScheetP et al.: Genotype, haplotype and copy-number variation in worldwide human populations.Nature451(7181) , 998–1003 (2008).
   PubMed Web of Science ®Google Scholar
• Wright S : Variability Within and Among Natural Populations. University of Chicago, Chicago, IL, USA, 4 (1978).
   Google Scholar
• Tham LS , GohBC, NafzigerA et al.: A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.Clin. Pharmacol. Ther.80(4) , 346–355 (2006).
   PubMed Web of Science ®Google Scholar
• Wadelius M , ChenLY, ErikssonN et al.: Association of warfarin dose with genes involved in its action and metabolism.Hum. Genet.121(1) , 23–34 (2007).
   PubMed Web of Science ®Google Scholar
• Yuan HY , ChenJJ, LeeMT et al.: A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.Hum. Mol. Genet.14(13) , 1745–1751 (2005).
   PubMed Web of Science ®Google Scholar
• Lee SC , NgSS, OldenburgJ et al.: Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population.Clin. Pharmacol. Ther.79(3) , 197–205 (2006).
   PubMed Web of Science ®Google Scholar
• Schwarz UI , RitchieMD, BradfordY et al.: Genetic determinants of response to warfarin during initial anticoagulation.N. Engl. J. Med.358(10) , 999–1008 (2008).
   PubMed Web of Science ®Google Scholar
• Relling MV : Polymorphic drug metabolism.Clin. Pharm.8(12) , 852–863 (1989).
   PubMedGoogle Scholar
• Kivisto KT , NiemiM: Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.Pharm. Res.24(2) , 239–247 (2007).
   PubMed Web of Science ®Google Scholar
• Nishizato Y , IeiriI, SuzukiH et al.: Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.Clin. Pharmacol. Ther.73(6) , 554–565 (2003).
   PubMed Web of Science ®Google Scholar
• Ho RH , ChoiL, LeeW et al.: Effect of drug transporter genotypes on pravastatin disposition in European– and African–American participants.Pharmacogenet. Genomics17(8) , 647–656 (2007).
   PubMed Web of Science ®Google Scholar
• Bosma PJ , ChowdhuryJR, BakkerC et al.: The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert‘s syndrome.N. Engl. J. Med.333(18) , 1171–1175 (1995).
   PubMed Web of Science ®Google Scholar
• Koiwai O , NishizawaM, HasadaK et al.: Gilbert‘s syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.Hum. Mol. Genet.4(7) , 1183–1186 (1995).
   PubMed Web of Science ®Google Scholar
• Ando Y , SakaH, AndoM et al.: Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.Cancer Res.60(24) , 6921–6926 (2000).
   PubMed Web of Science ®Google Scholar
• Innocenti F , UndeviaSD, IyerL et al.: Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.J. Clin. Oncol.22(8) , 1382–1388 (2004).
   PubMed Web of Science ®Google Scholar
• Iyer L , DasS, JanischL et al.: UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.Pharmacogenomics J.2(1) , 43–47 (2002).
   PubMedGoogle Scholar
• Rouits E , Boisdron-CelleM, DumontA, GuerinO, MorelA, GamelinE: Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients.Clin. Cancer Res.10(15) , 5151–5159 (2004).
   PubMed Web of Science ®Google Scholar
• Sai K , SaekiM, SaitoY et al.: UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.Clin. Pharmacol. Ther.75(6) , 501–515 (2004).
   PubMed Web of Science ®Google Scholar
• Toffoli G , CecchinE, GaspariniG et al.: Genotype-driven Phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer.J. Clin. Oncol.28(5) , 866–871 (2009).
   PubMed Web of Science ®Google Scholar
• Minami H , SaiK, SaekiM et al.: Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28.Pharmacogenet. Genomics17(7) , 497–504 (2007).
   PubMed Web of Science ®Google Scholar
• Onoue M , TeradaT, KobayashiM et al.: UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients.Int. J. Clin. Oncol.14(2) , 136–142 (2009).
   PubMed Web of Science ®Google Scholar
• Beutler E , GelbartT, DeminaA: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?Proc. Natl Acad. Sci. USA95(14) , 8170–8174 (1998).
   PubMed Web of Science ®Google Scholar
• Jada SR , LimR, WongCI et al.: Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients.Cancer Sci.98(9) , 1461–1467 (2007).
   PubMed Web of Science ®Google Scholar
• Johnson AD , KavousiM, SmithAV et al.: Genome-wide association meta-analysis for total serum bilirubin levels.Hum. Mol. Genet.18(14) , 2700–2710 (2009).
   PubMed Web of Science ®Google Scholar
• Sanna S , BusoneroF, MaschioA et al.: Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.Hum. Mol. Genet.18(14) , 2711–2718 (2009).
   PubMed Web of Science ®Google Scholar
• Pang GS , WangJ, WangZ, LeeCG: Predicting potentially functional SNPs in drug-response genes.Pharmacogenomics10(4) , 639–653 (2009).
   PubMed Web of Science ®Google Scholar
• Clark AG , HubiszMJ, BustamanteCD, WilliamsonSH, NielsenR: Ascertainment bias in studies of human genome-wide polymorphism.Genome Res.15(11) , 1496–1502 (2005).
   PubMed Web of Science ®Google Scholar
• Wall JD , CoxMP, MendezFL, WoernerA, SeversonT, HammerMF: A novel DNA sequence database for analyzing human demographic history.Genome Res.18(8) , 1354–1361 (2008).
   PubMed Web of Science ®Google Scholar
• Miller RD , PhillipsMS, JoI et al.: High-density single-nucleotide polymorphism maps of the human genome.Genomics86(2) , 117–126 (2005).
   PubMed Web of Science ®Google Scholar
• Chung WH , HungSI, HongHS et al.: Medical genetics: a marker for Stevens–Johnson syndrome.Nature428(6982) , 486 (2004).
   PubMed Web of Science ®Google Scholar
• Mallal S , PhillipsE, CarosiG et al.: HLA-B*5701 screening for hypersensitivity to abacavir.N. Engl. J. Med.358(6) , 568–579 (2008).
   PubMed Web of Science ®Google Scholar
• National Office of Public Health Genomics: 10 years of Public Health Genomics at CDC 1997–2007 (2007).
   Google Scholar
• The HUGO Pan-Asian SNP Consortium: Mapping human genetic diversity in Asia. Science326(5959) , 1541–1545 (2009).
   PubMed Web of Science ®Google Scholar
• Indian Genome Variation Consortium: Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet.87(1) , 3–20 (2008).
   PubMed Web of Science ®Google Scholar

▪ Websites

• Statistics Singapore www.singstat.gov.sg
   Google Scholar
• National University of Singapore, Centre for Medical Epidemiology www.nus-cme.org.sg/SGVP
   Google Scholar
• International HapMap Project www.hapmap.org
   Google Scholar
• Pharmacogenomics Knowledge Base www.pharmgkb.org
   Google Scholar
• 1000 Genomes www.1000genomes.org
   Google Scholar
• DrugBank www.drugbank.ca/genobrowse
   Google Scholar
• Sanger Institute: HapMap 3 www.sanger.ac.uk/humgen/hapmap3
   Google Scholar
• The ALlele FREquency Database http://alfred.med.yale.edu/alfred
   Google Scholar